General contraception guidance
|
|
|
| CEU Guidance – Quick Starting Contraception |
September 2010 |
September 2015 |
The UK Medical Eligibility Criteria for Contraceptive Use – November 2009
– UKMEC order form |
May 2010 |
|
| The UK Medical Eligibility Criteria for Contraceptive Use – Summary Sheets |
May 2010 |
|
| Management of Unscheduled Bleeding in Women Using Hormonal Contraception |
May 2009 |
May 2014 |
| UK Selected Practice Recommendations for Contraceptive Use (2002) |
2002 |
|
Method specific guidance
|
| Barrier Methods for Contraception and STI Prevention |
August 2012 |
August 2017 |
| Combined Hormonal Contraception |
October 2011 |
October 2016 |
| Missed Pill Recommendations |
May 2011 |
May 2012 |
| Progestogen-only Pills |
Updated June 2009 |
November 2013 |
| Progestogen-only Injectable Contraception |
Updated June 2009 |
October 2013 |
| Recommendation from the CEU: Antibiotic prophylaxis for intrauterine contraceptive use in women at risk of bacterial endocarditis |
July 2008 |
|
| Progestogen-only Implants |
April 2008 |
January 2013 |
| Intrauterine Contraception |
November 2007 |
April 2013 |
Emergency contraception
|
| Emergency contraception guidance |
Updated January 2012 |
August 2016 |
| Ulipristal (EllaOne) FAQs – Faculty Statement from the CEU |
December 2009 |
|
Contraception for special groups
|
| Contraception for women aged over 40 years |
July 2010 |
July 2015 |
| Contraceptive choices for young people |
March 2010 |
March 2015 |
| Postnatal Sexual and Reproductive Health |
September 2009 |
September 2014 |
| Sexual and Reproductive Health for Individuals with Inflammatory Bowel Disease |
June 2009 |
June 2014 |
| Oral Contraceptive Use And Cancer Risk |
September 2007 |
|
| Depo Provera and Young people – Faculty statement |
November 2004 |
|
Drug Interactions
|
| Drug Interactions with hormonal contraception |
Updated January 2012 |
January 2016 |
| CEU Statement – Antiepileptic Drugs and Contraception |
January 2010 |
|
General sexual & reproductive health guidance
|
| Management of Vaginal Discharge in Non-Genitourinary Medicine Settings |
February 2012 |
March 2012 |
Legal and drug licensing issues
|
| Joint statement with CEU regarding off- label prescribing |
December 2009 |
|
New Product Reviews & Statements
|
| CEU Statement – Contraceptive Options for Women with Prolactinoma |
September 2012 |
|
| CEU Statement – New Inserter for Mirena® IUS |
September 2012 |
|
| CEU Statement – Risk of venous thromboembolism in users of non-oral contraceptives |
May 2012 |
|
| CEU Statement – Hysteroscopic Sterilisation |
October 2010 |
|
| CEU Statement – Nexplanon® |
Updated November 2010 |
|
| Ulipristal Acetate (ellaOne®) |
October 2009 |
|
| The estradiol valerate / dienogest combined pill, Qlaira® |
September 2009 |
|
| Combined Vaginal Ring (NuvaRing®) |
March 2009 |
|
| FemCap – vaginal barrier contraceptive |
October 2004 |
|
| Evra – Norelgestromin/ethinyl oestradiol transdermal contraceptive system |
October 2003 |
|
| Cerazette – Desogestrel-only pill
Thats All,
To Your Success,
Hema xoxo
|
April 2003 |
|